Table 1.

Comparability of Prognostic Features Among Young and Old Patients

Favorable Parameter
% Patients P
<65 yr (N = 49) 65-69 yr (N = 39) ≥70 yr (N = 10)
Cytogenetics  74  64 90  .2  
B2M ≤2.5 mg/L  51  33  40  .2  
CRP ≤4.0 mg/L  53  38  60  .3  
≤12 mo of prior therapy 55  54  70  .6  
Non-IgA isotype  82  85  70 .6  
Sensitive  59  64  70  .8  
LDH ≤190 U/L 88  92  80  .5  
Stage <III  49  58  60 .6  
Albumin >3.5 g/dL  51  46  40  .8 
Creatinine ≤2 mg/dL  96  95  100  .8  
Second transplant  76  69  50  .3  
CD34 >5 × 106/kg  83  72  80  .4 
Favorable Parameter
% Patients P
<65 yr (N = 49) 65-69 yr (N = 39) ≥70 yr (N = 10)
Cytogenetics  74  64 90  .2  
B2M ≤2.5 mg/L  51  33  40  .2  
CRP ≤4.0 mg/L  53  38  60  .3  
≤12 mo of prior therapy 55  54  70  .6  
Non-IgA isotype  82  85  70 .6  
Sensitive  59  64  70  .8  
LDH ≤190 U/L 88  92  80  .5  
Stage <III  49  58  60 .6  
Albumin >3.5 g/dL  51  46  40  .8 
Creatinine ≤2 mg/dL  96  95  100  .8  
Second transplant  76  69  50  .3  
CD34 >5 × 106/kg  83  72  80  .4 
Close Modal

or Create an Account

Close Modal
Close Modal